Bempedoic acid/ezetimibe Interactions
There are 87 drugs known to interact with bempedoic acid/ezetimibe, along with 7 disease interactions. Of the total drug interactions, 31 are major, 52 are moderate, and4 are minor.
- View all 87 medications that may interact with bempedoic acid/ezetimibe
- View bempedoic acid/ezetimibe disease interactions (7)
Most frequently checked interactions
View interaction reports for bempedoic acid/ezetimibe and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Brilinta (ticagrelor)
- Bydureon (exenatide)
- Daily Multi-Vitamins with Minerals (multivitamin with minerals)
- Depo-Testosterone (testosterone)
- Flonase (fluticasone nasal)
- Ginger Root (ginger)
- GlipiZIDE XL (glipizide)
- Glyceryl T (guaifenesin / theophylline)
- Jardiance (empagliflozin)
- L-Arginine (arginine)
- L-Lysine (lysine)
- L-Methylfolate Formula (l-methylfolate)
- Lovaza (omega-3 polyunsaturated fatty acids)
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Micardis (telmisartan)
- Mounjaro (tirzepatide)
- Mucinex (guaifenesin)
- Nexletol (bempedoic acid)
- Ozempic (semaglutide)
- Paracetamol (acetaminophen)
- Praluent (alirocumab)
- Protonix (pantoprazole)
- Repatha (evolocumab)
- Rybelsus (semaglutide)
- Vitamin D3 (cholecalciferol)
Bempedoic acid/ezetimibe disease interactions
There are 7 disease interactions with bempedoic acid/ezetimibe which include:
- liver disease
- hepatic impairment
- hyperuricemia
- renal impairment
- tendon injuries
- myopathy/rhabdomyolysis
- renal impairment
More about bempedoic acid/ezetimibe
- bempedoic acid/ezetimibe consumer information
- Compare alternatives
- Reviews (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: antihyperlipidemic combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.